Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Researchers from University of Otago discuss findings in vaccines
June 11th, 2008
Investigators publish new data in the report 'Immunostimulatory biodegradable implants containing the adjuvant Quil-A--Part II: In vivo evaluation.' "Sustained-release formulations have drawn the attention of formulation scientists working in the area of vaccine research because these systems may reduce the need for booster immunisations. This would be of great advantage especially for the administration of subunit vaccines," researchers in Dunedin, New Zealand report. "The aim of this study was to illustrate the performance of liposome-forming, sustained-release lipid implants containing 2% of the adjuvant Quil-A (QA) (w/w of total lipids) and ovalbumin (OVA) as a...
Source: Vaccine Weekly (2008-06-11)
|
